Chen Mao Xiang, Sandow Shaun L, Doceul Virginie, Chen Yu Hua, Harper Heather, Hamilton Bruce, Meadows Helen J, Trezise Derek J, Clare Jeff J
BR&AD, GlaxoSmithKline R&D, Stevenage, UK.
BMC Biotechnol. 2007 Dec 20;7:93. doi: 10.1186/1472-6750-7-93.
HERG potassium channel blockade is the major cause for drug-induced long QT syndrome, which sometimes cause cardiac disrhythmias and sudden death. There is a strong interest in the pharmaceutical industry to develop high quality medium to high-throughput assays for detecting compounds with potential cardiac liability at the earliest stages of drug development. Cultivation of cells at lower temperature has been used to improve the folding and membrane localization of trafficking defective hERG mutant proteins. The objective of this study was to investigate the effect of lower temperature maintenance on wild type hERG expression and assay performance.
Wild type hERG was stably expressed in CHO-K1 cells, with the majority of channel protein being located in the cytoplasm, but relatively little on the cell surface. Expression at both locations was increased several-fold by cultivation at lower growth temperatures. Intracellular hERG protein levels were highest at 27 degrees C and this correlated with maximal 3H-dofetilide binding activity. In contrast, the expression of functionally active cell surface-associated hERG measured by patch clamp electrophysiology was optimal at 30 degrees C. The majority of the cytoplasmic hERG protein was associated with the membranes of cytoplasmic vesicles, which markedly increased in quantity and size at lower temperatures or in the presence of the Ca2+-ATPase inhibitor, thapsigargin. Incubation with the endocytic trafficking blocker, nocodazole, led to an increase in hERG activity at 37 degrees C, but not at 30 degrees C.
Our results are consistent with the concept that maintenance of cells at reduced temperature can be used to boost the functional expression of difficult-to-express membrane proteins and improve the quality of assays for medium to high-throughput compound screening. In addition, these results shed some light on the trafficking of hERG protein under these growth conditions.
人乙醚 - 去极化相关基因(HERG)钾通道阻滞是药物诱导的长QT综合征的主要原因,长QT综合征有时会导致心律失常和猝死。制药行业对开发高质量的中高通量检测方法有着浓厚兴趣,以便在药物研发的最早阶段检测出具有潜在心脏风险的化合物。在较低温度下培养细胞已被用于改善运输缺陷型hERG突变蛋白的折叠和膜定位。本研究的目的是探讨低温维持对野生型hERG表达及检测性能的影响。
野生型hERG在CHO - K1细胞中稳定表达,大部分通道蛋白位于细胞质中,但细胞表面相对较少。在较低生长温度下培养,两个位置的表达均增加了几倍。细胞内hERG蛋白水平在27摄氏度时最高,这与最大的3H - 多非利特结合活性相关。相比之下,通过膜片钳电生理学测量的功能活性细胞表面相关hERG的表达在30摄氏度时最佳。大部分细胞质hERG蛋白与细胞质囊泡膜相关,在较低温度下或存在Ca2 + - ATP酶抑制剂毒胡萝卜素时,其数量和大小显著增加。用胞吞运输阻滞剂诺考达唑孵育导致hERG活性在37摄氏度时增加,但在30摄氏度时未增加。
我们的结果与以下概念一致,即降低温度维持细胞可用于提高难以表达的膜蛋白的功能表达,并改善中高通量化合物筛选检测的质量。此外,这些结果为这些生长条件下hERG蛋白的运输提供了一些线索。